_version_ |
1796982259738214400
|
author |
Sin Chew Daily
|
author_facet |
Sin Chew Daily
|
author_sort |
Sin Chew Daily
|
collection |
UPM
|
first_indexed |
2024-03-06T10:49:24Z
|
format |
Newspaper
|
id |
upm.eprints-90136
|
institution |
Universiti Putra Malaysia
|
language |
English
|
last_indexed |
2024-03-06T10:49:24Z
|
publishDate |
2021
|
record_format |
dspace
|
spelling |
upm.eprints-901362021-09-07T10:37:51Z http://psasir.upm.edu.my/id/eprint/90136/ IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster Sin Chew Daily 2021-07-06 Newspaper NonPeerReviewed image en http://psasir.upm.edu.my/id/eprint/90136/1/Imr%20the%20nationally%20produced%20vaccine%20is%20expected%20to%20be%20available%20in%202024%20and%20is%20listed%20as%20a%20booster.jpg Sin Chew Daily IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster. in Sin Chew Daily, (6 July 2021), p. 3. (Call Number: 2021/07-011)
|
spellingShingle |
Sin Chew Daily
IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster
|
title |
IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster
|
title_full |
IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster
|
title_fullStr |
IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster
|
title_full_unstemmed |
IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster
|
title_short |
IMR, the nationally produced vaccine is expected to be available in 2024 and is listed as a booster
|
title_sort |
imr the nationally produced vaccine is expected to be available in 2024 and is listed as a booster
|
url |
http://psasir.upm.edu.my/id/eprint/90136/1/Imr%20the%20nationally%20produced%20vaccine%20is%20expected%20to%20be%20available%20in%202024%20and%20is%20listed%20as%20a%20booster.jpg
|
work_keys_str_mv |
AT sinchewdaily imrthenationallyproducedvaccineisexpectedtobeavailablein2024andislistedasabooster
|